ongo
outbreak
recent
emerg
novel
coronaviru
pose
challeng
public
health
laboratori
viru
isol
unavail
grow
evid
outbreak
widespread
initi
thought
intern
spread
travel
alreadi
occur
aim
aim
develop
deploy
robust
diagnost
methodolog
use
public
health
laboratori
set
without
viru
materi
avail
method
present
valid
diagnost
workflow
design
reli
close
genet
related
sar
coronaviru
make
use
synthet
nucleic
acid
technolog
result
workflow
reliabl
detect
discrimin
sarscov
coordin
academ
public
laboratori
confirm
assay
exclus
base
origin
clinic
specimen
contain
full
spectrum
human
respiratori
virus
control
materi
made
avail
european
viru
archiv
global
evag
european
union
infrastructur
project
conclus
present
studi
demonstr
enorm
respons
capac
achiev
coordin
academ
public
laboratori
nation
european
research
network
accord
world
health
organ
china
countri
offic
inform
case
pneumonia
unknown
aetiolog
wuhan
citi
hubei
provinc
decemb
novel
coronaviru
current
term
offici
announc
caus
agent
chines
author
januari
viral
genom
sequenc
releas
immedi
public
health
support
via
commun
onlin
resourc
virologicalorg
januari
genbank
access
number
follow
four
genom
deposit
januari
viral
sequenc
databas
curat
global
initi
share
influenza
data
gisaid
genom
sequenc
suggest
presenc
viru
close
relat
member
viral
speci
term
sever
acut
respiratori
syndrom
sar
relat
cov
speci
defin
agent
outbreak
sar
human
speci
also
compris
larg
number
virus
mostli
detect
rhinolophid
bat
asia
europ
januari
laboratoryconfirm
human
case
notifi
confirm
case
travel
wuhan
announc
januari
thailand
well
januari
japan
januari
korea
extent
humantohuman
transmiss
unclear
time
write
report
evid
humantohuman
transmiss
among
foremost
prioriti
facilit
public
health
intervent
reliabl
laboratori
diagnosi
acut
respiratori
infect
rtpcr
routin
use
detect
caus
virus
respiratori
secret
previous
demonstr
feasibl
introduc
robust
detect
technolog
base
realtim
rtpcr
public
health
laboratori
intern
health
emerg
coordin
public
academ
laboratori
situat
viru
isol
avail
primari
substrat
establish
control
assay
assay
perform
present
case
viru
isol
sampl
infect
patient
far
becom
avail
intern
public
health
commun
report
establish
valid
diagnost
workflow
screen
specif
confirm
design
absenc
avail
viru
isol
origin
patient
specimen
design
valid
enabl
close
genet
related
sarscov
aid
use
synthet
nucleic
acid
technolog
cell
cultur
supernat
contain
type
coronavirus
respiratori
virus
provid
univers
hong
kong
research
laboratori
respiratori
sampl
obtain
patient
hospitalis
medic
centr
test
nxtag
respiratori
pathogen
panel
luminex
netherland
case
merscov
merscov
upe
assay
publish
rna
extract
clinic
sampl
magna
pure
system
roch
penzberg
germani
cell
cultur
supernat
viral
rna
mini
kit
qiagen
hilden
germani
reaction
contain
rna
reaction
buffer
provid
superscript
iii
one
step
rtpcr
system
platinum
taq
polymeras
invitrogen
darmstadt
germani
contain
mm
deoxyribont
triphosph
dntp
mm
magnesium
sulphat
revers
transcriptas
taq
mixtur
kit
mm
magnesium
sulphat
solut
invitrogen
nonacetyl
bovin
serum
albumin
roch
primer
probe
sequenc
well
optimis
concentr
shown
tabl
oligonucleotid
synthesis
provid
tibmolbiol
berlin
laboratori
particip
evalu
use
taqman
fast
viru
master
mix
thermo
fisher
oligonucleotid
concentr
cycl
condit
qiagen
onestep
rtpcr
kit
also
test
found
compat
intend
crossreact
assay
viral
rna
sarscov
allow
us
use
assay
without
reli
extern
sourc
specif
rna
routin
workflow
recommend
e
gene
assay
firstlin
screen
tool
follow
confirmatori
test
rdrp
gene
assay
applic
rdrp
gene
assay
dual
colour
technolog
discrimin
probe
posit
sarscov
rna
latter
use
posit
control
altern
laboratori
may
choos
run
rdrp
assay
probe
intern
use
sampl
diagnost
workflow
optimis
agre
medic
ethic
rule
particip
partner
public
releas
viru
sequenc
case
reli
social
media
report
announc
detect
sarslik
viru
thu
assum
sarsrel
cov
involv
outbreak
download
complet
partial
nt
sarsrel
viru
sequenc
avail
genbank
januari
list
n
entri
manual
check
artifici
sequenc
laboratoryderiv
synthet
etc
well
sequenc
duplic
remov
result
final
list
sequenc
sequenc
align
align
use
assay
design
supplementari
figur
upon
releas
first
sequenc
virolog
org
three
assay
select
base
well
match
genom
figur
align
complement
addit
sequenc
releas
independ
gisaid
http
www
gisaidorg
confirm
good
match
select
primer
sequenc
align
primer
bind
domain
sarscov
well
select
batassoci
sarsrel
cov
shown
figur
obtain
preliminari
assess
analyt
sensit
use
purifi
cell
cultur
supernat
contain
sarscov
strain
virion
grown
vero
cell
supernat
ultrafilt
therebi
concentr
ca
volum
cell
cultur
supernat
concentr
step
simultan
reduc
rel
concentr
background
nucleic
acid
virionpackag
viral
rna
virion
prepar
quantifi
realtim
rtpcr
use
specif
vitrotranscrib
rna
quantif
standard
describ
drosten
et
al
assay
subject
replic
test
order
determin
stochast
detect
frequenc
assay
sensit
end
point
figur
b
assay
highli
sensit
best
result
obtain
e
gene
rdrp
gene
assay
copi
per
reaction
detect
probabl
respect
two
assay
chosen
evalu
one
laboratori
particip
extern
evalu
use
basic
rtpcr
reagent
taqman
fast
viru
master
mix
repeat
sensit
studi
equival
result
e
gene
rna
copiesreact
ci
rdrp
rna
copiesreact
ci
note
n
gene
assay
also
perform
well
subject
intens
valid
slightli
less
sensit
supplementari
figur
although
assay
detect
without
polymorph
oligonucleotid
bind
site
figur
addit
gener
vitrotranscrib
rna
standard
exactli
match
sequenc
absolut
quantif
studi
limit
detect
lod
replic
reaction
done
concentr
around
detect
end
point
determin
preliminari
dilut
experi
result
lod
replic
test
copi
per
reaction
e
gene
assay
copi
per
reaction
rdrp
assay
figur
figur
close
hit
rate
copi
per
reaction
accord
poisson
distribut
expect
one
rna
molecul
detect
follow
rational
sarscov
rna
use
posit
control
entir
laboratori
procedur
thu
obviat
need
handl
rna
formul
rdrp
assay
contain
two
probe
broadrang
probe
react
sarscov
addit
probe
react
limit
dilut
experi
confirm
probe
whether
use
individu
combin
provid
lod
target
viru
specif
probe
detect
rna
transcript
sarscov
rna
present
potenti
exposur
common
environment
sourc
earli
report
case
implic
possibl
independ
zoonot
infect
increas
sequenc
variabl
show
assay
detect
batassoci
sarsrel
virus
use
e
gene
assay
test
six
batderiv
faecal
sampl
avail
drexler
et
al
und
muth
et
al
virusposit
sampl
stem
european
rhinolophid
bat
detect
phylogenet
outlier
within
sarsrel
cov
clade
suggest
asian
virus
like
detect
would
theoret
ensur
broad
sensit
even
case
multipl
independ
acquisit
variant
virus
anim
reservoir
exclud
nonspecif
reactiv
oligonucleotid
among
caus
artifici
fluoresc
signal
assay
test
time
parallel
water
nucleic
acid
except
provid
oligonucleotid
none
reaction
posit
signal
detect
cell
cultur
supernat
contain
endem
human
coronavirus
hcov
well
merscov
test
duplic
three
assay
tabl
noncultiv
supernat
human
airway
cultur
use
viral
rna
concentr
sampl
determin
specif
realtim
rtpcr
vitrotranscrib
rna
standard
design
absolut
quantif
viral
load
addit
undilut
quantifi
cell
cultur
supernat
test
summaris
tabl
addit
mix
neg
human
sputum
sampl
none
test
virus
viru
prepar
show
reactiv
assay
use
e
rdrp
gene
assay
test
total
clinic
sampl
patient
respiratori
diseas
biobank
five
laboratori
provid
diagnost
servic
one
germani
two
netherland
one
hong
kong
one
uk
select
sampl
three
univers
medic
centr
patient
gener
intens
care
ward
well
mainli
paediatr
outpati
depart
seen
germani
netherland
hong
kong
remain
sampl
contribut
nation
public
health
servic
perform
surveil
studi
rivm
phe
sampl
mainli
submit
practition
sampl
contain
broadest
rang
respiratori
agent
possibl
reflect
gener
spectrum
viru
concentr
encount
diagnost
laboratori
countri
tabl
total
test
yield
fals
posit
outcom
four
individu
test
reaction
weak
initi
reactiv
seen
neg
upon
retest
assay
signal
associ
particular
viru
viru
initi
posit
reactiv
occur
sampl
contain
viru
higher
concentr
test
posit
given
result
extens
technic
qualif
describ
conclud
initi
reactiv
due
chemic
instabl
realtim
pcr
probe
probabl
handl
issu
caus
rapid
introduct
new
diagnost
test
control
evalu
studi
present
report
describ
establish
diagnost
workflow
detect
emerg
viru
absenc
physic
sourc
viral
genom
nucleic
acid
effect
assay
design
enabl
willing
scientist
china
share
genom
inform
formal
public
well
avail
broad
sequenc
knowledg
ca
year
investig
sarsrel
virus
anim
reservoir
rel
eas
assay
could
design
viru
contrast
sarscov
prove
huge
collect
valu
descript
studi
diseas
ecolog
viral
genom
divers
realtim
rtpcr
wide
deploy
diagnost
virolog
case
public
health
emerg
profici
diagnost
laboratori
reli
robust
technolog
establish
new
diagnost
test
within
routin
servic
preformul
assay
becom
avail
addit
inform
isol
human
airway
epitheli
cultur
rna
copiesml
determin
specif
realtim
rtpcr
one
isol
isol
quantifi
spike
human
negativetest
sputum
e
rna
copiesml
determin
specif
realtim
rtpcr
f
rna
copiesml
determin
specif
realtim
rtpcr
one
isol
isol
quantifi
spike
human
negativetest
sputum
g
rna
copiesml
determin
specif
realtim
rtpcr
reagent
oligonucleotid
posit
control
laboratori
work
qualiti
control
programm
need
reli
document
technic
qualif
assay
formul
well
data
extern
clinic
evalu
test
provis
control
rna
templat
effect
implement
evag
project
provid
virusrel
reagent
academ
research
collect
sarscov
rna
retriev
evag
present
outbreak
specif
product
rna
transcript
heredescrib
assay
first
retriev
evag
onlin
catalogu
januari
http
wwweuropeanvirusarchivecom
technic
qualif
data
base
cell
cultur
materi
synthet
construct
well
result
exclus
test
clinic
sampl
includ
first
version
diagnost
protocol
provid
januari
base
effici
collabor
inform
network
laboratori
data
augment
within
week
compris
test
result
base
wide
rang
respiratori
pathogen
clinic
sampl
natur
infect
compar
evalu
studi
regulatori
qualif
vitro
diagnost
assay
take
month
organis
legal
implement
logist
typic
come
peak
outbreak
wane
speed
effect
present
deploy
evalu
effort
enabl
nation
european
research
network
establish
respons
intern
health
crise
recent
year
demonstr
enorm
respons
capac
releas
coordin
action
academ
public
laboratori
laboratori
capac
support
immedi
public
health
intervent
enabl
site
enrol
patient
rapid
clinic
research
respons
cd
plan
experi
conceptualis
laboratori
work
conceptualis
overal
studi
wrote
manuscript
draft
